1. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
   Luis Paz-Ares et al, 2023, Journal of Clinical Oncology CrossRef
2. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
   Apar Kishor P. Ganti et al, 2021, Journal of the National Comprehensive Cancer Network CrossRef
3. Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
   Sheng-Jie Sun et al, 2022, World Journal of Clinical Cases CrossRef
4. Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
   Lowell Hart et al, 2023, Cancer Medicine CrossRef
5. Cytotoxicity and Multi-Enzyme Inhibition of Nepenthes miranda Stem Extract on H838 Human Non-Small Cell Lung Cancer Cells and RPA32, Elastase, Tyrosinase, and Hyaluronidase Proteins
   Ching-Yi Lee et al, 2024, Plants CrossRef
6. Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case–Control Study
   Rémy Ezzedine et al, 2023, Cancers CrossRef
7. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
   Alessio Stefani et al, 2022, Frontiers in Oncology CrossRef
8. Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study
   Christian Bailly et al, 2023, Molecules CrossRef